Speclipse is the global leader in medical diagnostic technology utilizing laser spectroscopy and artificial intelligence. Here, the company presents a game-changing solution to skin cancer detection, called, “Spectra-Scope”. Spectra-Scope delivers real-time and non-invasive skin cancer detection with over 95% diagnostic accuracy. This is made possible through the use of laser-induced plasma spectroscopy and a proprietary deep learning-based diagnostic algorithm.
Skin cancer is the easiest cancer to find, yet a confirmed diagnosis takes time, skills, and expert judgment, along with various diagnostic tests like dermoscopy and biopsy. With Spectra-Scope®, physicians can make instant, scar-free, and highly accurate diagnosis for all types of skin cancers. It is simple to use. The combination of biochemical information on skin tissue as determined through laser-induced plasma spectroscopy plus the proprietary AI-based diagnostic algorithm create an almost immediate diagnosis of unrivaled clinical accuracy in both sensitivity and specificity.
Speclipse, Inc., a medical device company founded by Stanford University graduates and a dermatologist, offers the world first cancer diagnostic solution based on Laser-Induced Plasma Spectroscopy (LIPS) and Artificial Intelligence (AI) Technology. Its core technology, Spectra-Scope®, embodies a new solution to the diagnosis of skin cancers without compromising efficacy and accuracy, therefore preventing unnecessary biopsy.
We know everyone is unique and deserve their very own approach to their skin treatment. So whether you need some advice or are ready for treatment, we invite you to make an appointment today so we can assist you in experiencing a positive journey to better skin and a more confident future.
